SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-19-000081
Filing Date
2019-10-30
Accepted
2019-10-30 16:07:01
Documents
48
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20190930.htm   iXBRL 10-Q 1039720
2 EXHIBIT 31.1 lfvn093019ex311.htm EX-31.1 10999
3 EXHIBIT 31.2 lfvn093019ex312.htm EX-31.2 10988
4 EXHIBIT 32.1 lfvn093019ex321.htm EX-32.1 5864
5 EXHIBIT 32.2 lfvn093019ex322.htm EX-32.2 5853
  Complete submission text file 0000849146-19-000081.txt   4187720

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20190930.xsd EX-101.SCH 24889
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20190930_cal.xml EX-101.CAL 63367
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20190930_def.xml EX-101.DEF 100091
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20190930_lab.xml EX-101.LAB 395869
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20190930_pre.xml EX-101.PRE 234637
27 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20190930_htm.xml XML 561571
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 191180052
SIC: 2834 Pharmaceutical Preparations